4//SEC Filing
Almenoff June Sherie 4
Accession 0001578563-25-000199
CIK 0001534120other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:22 PM ET
Size
8.1 KB
Accession
0001578563-25-000199
Insider Transaction Report
Form 4
Almenoff June Sherie
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-28+3,167→ 3,167 total - Exercise/Conversion
Restricted Stock Units
2025-03-28−3,167→ 6,333 total→ Common Stock (3,167 underlying)
Holdings
- 1,000(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
- [F3]On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001492647
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:22 PM ET
- Size
- 8.1 KB